||
https://mp.weixin.qq.com/s/QpH16DeHFb8NTVW-5hnwRA
诺华在全球范围深度拓展放射配体疗法的影响力,全方位携手国内的行业协会、医疗机构和行业伙伴,必定会以前所未有的力度推进核医学产业标准化进程,以磅礴之势助力中国核医学及核医疗产业铸就高质量发展的辉煌蓝图,以非凡之能提升放射配体疗法的卓越服务,让患者生存期得以更长延续,生活质量得到显著提升。
http://www.pubmedplus.cn/P/SearchQuickResult?wd=434ebaa9-263f-453b-b2f5-fb06a6c0821c
01. | Binding, Competitive | 235 篇 | 100.000% |
02. | Radioligand Assay | 235 篇 | 100.000% |
03. | Animals | 184 篇 | 78.298% |
04. | Humans | 132 篇 | 56.170% |
05. | Male | 125 篇 | 53.191% |
06. | Rats | 113 篇 | 48.085% |
07. | Female | 60 篇 | 25.532% |
08. | Mice | 51 篇 | 21.702% |
09. | Rats, Sprague-Dawley | 51 篇 | 21.702% |
10. | Dose-Response Relationship, Drug | 43 篇 | 18.298% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-11-23 06:30
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社